Literature DB >> 23493339

Endovascular management of six simultaneous intracranial dural arteriovenous fistulas in a single patient.

Taylor L Gist1, Leonardo Rangel-Castilla, Chandan Krishna, Gustavo C Roman, David A Cech, Orlando Diaz.   

Abstract

A 64-year-old man with a history of traumatic brain injury 4 years previously presented with progressive cognitive decline and gait abnormality. MRI revealed diffusion restriction in the bilateral centrum semiovale and multiple serpiginous flow voids. Cerebral angiogram revealed a total of six intracranial dural arteriovenous fistulas with separate fistulas of the right and left sphenoid bones, left clival plexus, right transverse sinus, right sigmoid sinus, and superior sagittal sinus. A diffuse pseudophlebitic pattern of venous drainage indicating severe venous hypertension was also observed. The patient underwent a series of endovascular treatments over the next 10 months to achieve resolution of all arteriovenous shunting. Repeat MRI showed resolution of the diffusion restriction and marked reduction in T2 vascular flow voids. The patient's clinical status improved significantly over the course of treatment, paralleling the improvement in venous hypertension.

Entities:  

Keywords:  Angiography; Embolic; Fistula; Liquid Embolic Material; Technique

Mesh:

Year:  2013        PMID: 23493339     DOI: 10.1136/neurintsurg-2012-010619.rep

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  3 in total

1.  Complete Reversal of Diffusion Restriction after Treatment of Traumatic Carotid-Cavernous Fistula.

Authors:  Jeong Hyun Shim; Inbo Han
Journal:  Korean J Neurotrauma       Date:  2017-10-31

2.  Progress in research on intracranial multiple dural arteriovenous fistulas.

Authors:  Yunbao Guo; Jing Yu; Ying Zhao; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-11-21

Review 3.  Endovascular treatment for dural arteriovenous fistulas in the petroclival region.

Authors:  Kun Hou; Xianli Lv; Lai Qu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.